The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
GLP-1 is in the glucagon pathway. As you recall, fat is mobilized from body fat stores and then it's burned up. It's oxidized in cells. It actually needs to be converted into ATP. Those fatty acids are essentially converted into ATP in the mitochondria of the cell. High insulin prevents that from happening and glucagon facilitates that process. Glucagon facilitates that process through increases in GLP-1.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.